Company news

Viatris Inc. news in 2021

Viatris Inc.'s news releases, calls and decks from 2021, newest first.

View company

Viatris Wins Court Decisions on Sanofi Appeals of Lantus® Patent Invalidations

December 28, 2021

Viatris to Move its Investor Event Previously Scheduled for January 7 to no Later Than February 28 When the Company Expects to Report its Fourth Quarter 2021 Results

December 16, 2021

Viatris Named by Newsweek as One of America's Most Responsible Companies

December 5, 2021

Viatris Wins Federal Circuit Court Appeal Upholding District Court Decision Invalidating Biogen's Tecfidera® Patent

November 30, 2021

Viatris to Participate in Evercore ISI 4th Annual HealthCONx Conference

November 17, 2021

Viatris and Biocon Biologics Announce Launch of Interchangeable SEMGLEE® (insulin glargine-yfgn) Injection and Insulin Glargine (insulin glargine-yfgn) Injection

November 15, 2021

Viatris Donates $1 Million as Founding Champion to New Orleans-based SBP's "Got Your Back" fund in Support of Housing Solutions for Veterans in Disaster-Impacted Communities

November 10, 2021

Viatris Reports Strong Third Quarter Results, Raises 2021 Financial Guidance and Announces Virtual Investor Event on January 7, 2022

November 7, 2021

Viatris' First-Ever Interchangeable Insulin Biosimilar Preferred on Express Scripts' Largest Formulary

October 19, 2021

Viatris Inc. to Release Third Quarter 2021 Financial Results on Nov. 8, 2021

October 12, 2021

Viatris Named Fifth on Fortune's Change the World List

October 10, 2021

Viatris Inc. to Participate in Citi's 16th Annual BioPharma Conference

August 29, 2021

Viatris Inc. to Participate in BofA Global Healthcare Conference

August 29, 2021

Viatris Reports Strong Second Quarter Results

August 8, 2021

Viatris Inc. and Biocon Biologics Receive Historic Approval for First Interchangeable Biosimilar Semglee® (insulin glargine-yfgn injection) for the Treatment of Diabetes

July 27, 2021

Mylan Wins Dismissal of Kansas EpiPen® Direct Purchaser Case

July 26, 2021

Viatris Inc. to Release Second Quarter 2021 Financial Results on Aug. 9, 2021

July 7, 2021

Viatris Inc. to Participate in Goldman Sachs 42nd Annual Global Healthcare Conference

May 24, 2021

Viatris Inc. Reports Strong First Quarter 2021 Financial Results, Reaffirms 2021 Guidance and Announces Inaugural Quarterly Dividend

May 9, 2021

Viatris Inc. Releases Inaugural Sustainability Report, Reinforcing its Commitment to Better Health and Better Communities Worldwide

May 5, 2021

Viatris Inc. to Participate in the 2021 RBC Capital Markets Global Healthcare Conference

April 29, 2021

Viatris Inc. to Participate in BofA Securities 2021 Health Care Conference

April 28, 2021

Viatris Inc. to Release First Quarter 2021 Financial Results on May 10, 2021

April 11, 2021

Viatris Inc. and Kindeva Drug Delivery Announce FDA Tentative Approval of the First Abbreviated New Drug Application Generic Version of Symbicort® (budesonide/formoterol fumarate dihydrate) Inhalation Aerosol

March 7, 2021

Viatris Inc. to Participate in Barclays Global Healthcare Conference

March 3, 2021

Viatris Inc. Hosts Inaugural Investor Day Outlining Unique and Differentiated Business Model, High-Quality Operational Platform, and Focus on CSR and Financial Commitments

February 28, 2021

Viatris Inc. Announces 2021 Financial Guidance and Reaffirms Strategic and Financial Commitments

February 21, 2021

Viatris Inc. to Hold Conference Call on Monday, Feb. 22, 2021, to Discuss 2021 Financial Guidance

February 8, 2021

Calls in 2021

Decks in 2021